drugset / Trial / NCT05099601

Silymarin Cream Versus Combined Silymarin Cream and Microneedling in Treatment of Melasma

NCT05099601

Phase 4 Unknown 30 enrolled Assiut University
NaSingle-groupOpen-labelTreatment

Summary

Melasma is an acquired pigmentary disorder, occurring most commonly on the face. It is more prevalent in females and darker skin types. Melasma is mainly a clinical diagnosis consisting of symmetric reticulated hypermelanosis in three predominant facial patterns: centrofacial, malar, and mandibular. Melasma, though benign, can be extremely psychologically distressing and has been shown to have a significant impact on quality of life, social and emotional wellbeing. Multiple factors are implicated in the pathogenesis of melasma; however, the definite underlying mechanisms are not yet completely established. Ultraviolet exposure is one of the leading etiological factors, besides genetic and hormonal factors.

Timeline

Start
2022-05
Primary completion
2022-12
Completion
2022-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Silymarin Traditional medicine (herbal / TCM) 0.7 % Topical